Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (3125)	9/16/2005 7:54:33 AM
From: IRWIN JAMES FRANKEL	Read Replies (1) \| Respond to of 12215

>>Growing hedgehog hair on all those bald heads should be worth $5 billion in market cap alone. My hair is OK. Is anyone working on growing me* some new brain cells? :-) ij * I could use some. Any other takers?

To: BulbaMan who wrote (3125)	9/19/2005 8:37:40 AM
From: tom pope	Respond to of 12215

Here you go, BulbaMan. Not enough for 20X, but useful: CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sept. 19, 2005--Curis, Inc. (NASDAQ: CRIS - News), a therapeutic drug development company, today announced that the Company has entered into an exclusive worldwide research and development agreement with Procter & Gamble Pharmaceuticals, a division of The Procter & Gamble Company (NYSE: PG - News), to evaluate and develop potential treatments for hair growth regulation utilizing Curis' Hedgehog agonist technology. Future efforts may be expanded to address other skin disorders. To date, Curis scientists have demonstrated that small molecule Hedgehog agonists can induce hair growth in pre-clinical models.